Aspire Biopharma Holdings Inc
NASDAQ:ASBP
Aspire Biopharma Holdings Inc
NASDAQ:ASBP
Price:
1.06
USD
-11.67%
Market Closed
Market Cap:
$5.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Aspire Biopharma Holdings Inc
NASDAQ:ASBP
|
PR |
|
Crypto Co
OTC:CRCW
|
US |
|
Lombard Medical Inc
OTC:EVARF
|
UK |
|
S
|
Sanofi SA
XBER:SNW
|
FR |
|
Anabuki Kosan Inc
TSE:8928
|
JP |
|
Y
|
York Space Systems Inc
NYSE:YSS
|
US |
|
C
|
China Fishery Group Ltd
SGX:B0Z
|
HK |
|
D
|
DigiMax Global Inc
OTC:DBKSF
|
CA |
Cash Flow Statement
Cash Flow Statement
Aspire Biopharma Holdings Inc
Aspire Biopharma Holdings Inc
Currency: USD
| Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||
| Net Income |
0
|
1
|
3
|
6
|
8
|
7
|
4
|
(1)
|
(3)
|
(4)
|
(13)
|
(26)
|
(27)
|
(29)
|
|
| Other Non-Cash Items |
(0)
|
(2)
|
(4)
|
(8)
|
(9)
|
(8)
|
(6)
|
(3)
|
(1)
|
(0)
|
9
|
24
|
25
|
26
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(1)
|
(1)
|
(0)
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
(0)
|
|
| Cash from Operating Activities |
(1)
N/A
|
(1)
+11%
|
(1)
-22%
|
(0)
+79%
|
(0)
-50%
|
(1)
-20%
|
(1)
-21%
|
(3)
-318%
|
(3)
-15%
|
(3)
+5%
|
(2)
+31%
|
(2)
+25%
|
(2)
-36%
|
(3)
-54%
|
|
| Investing Cash Flow | |||||||||||||||
| Other Items |
(295)
|
(295)
|
(295)
|
0
|
284
|
285
|
285
|
0
|
15
|
14
|
14
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(295)
N/A
|
(295)
N/A
|
(295)
N/A
|
0
N/A
|
284
N/A
|
285
+0%
|
285
0%
|
0
N/A
|
15
N/A
|
14
-4%
|
14
-2%
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Financing Cash Flow | |||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
(284)
|
(285)
|
(285)
|
0
|
(15)
|
(14)
|
(14)
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
2
|
5
|
2
|
6
|
|
| Other |
297
|
297
|
297
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
(1)
|
|
| Cash from Financing Activities |
297
N/A
|
296
0%
|
297
+0%
|
0
N/A
|
(284)
N/A
|
(285)
0%
|
(285)
+0%
|
(283)
+1%
|
(11)
+96%
|
(11)
+6%
|
(12)
-8%
|
(11)
+7%
|
2
N/A
|
5
+120%
|
|
| Change in Cash | |||||||||||||||
| Net Change in Cash |
1
N/A
|
1
-7%
|
0
-8%
|
(0)
N/A
|
(0)
-50%
|
(1)
-20%
|
(0)
+8%
|
(0)
+36%
|
0
N/A
|
0
+661%
|
0
N/A
|
1
N/A
|
0
-85%
|
2
+860%
|
|
| Free Cash Flow | |||||||||||||||
| Free Cash Flow |
(1)
N/A
|
(1)
+11%
|
(1)
-22%
|
(0)
+79%
|
(0)
-50%
|
(1)
-20%
|
(1)
-21%
|
(3)
-318%
|
(3)
-15%
|
(3)
+5%
|
(2)
+31%
|
(2)
+25%
|
(2)
-36%
|
(3)
-54%
|
|
Switch to:
Switch to:
See Also
Discover More
